This is a SIGNAL-AMPLIFIED, REAL-TIME THERAPEUTIC DRUG MONITORING DEVICE contract awarded to Lynntech Inc., a small business, by the Defense Advanced Research Projects Agency (DARPA) under the Small Business Innovation Research (SBIR) Program Phase II. The $1,496,846.00 cost-plus-fixed-fee contract was awarded on December 20, 2017, with a completion date of February 19, 2021. The contract is for research and development of a device to provide real-time monitoring of therapeutic drug levels, which can be useful for optimizing patient treatment. Lynntech is a small business that specializes in transitioning science and engineering into solutions for real-world applications, including developing biomedical devices, diagnostic tests, and monitoring technologies for government agencies.
Generated 3/22/24, 12:01 AM